Anti-Cancer Immuno-Therapy Improvement
development of new cancer-specific immune receptors
T cells
EN-ACTI2NG program
improved T cell-mediated cancer immuno-therapies
research-specific skills
train PhD students
modification of CAR
European Network
career development
product development
molecular modification
engineered tumor-specific immune receptors
Nanoscale Geometry
biophysical analysis of immune receptors
European Community
TCR Interactions
communication skills
individual research projects
industrial research environments
efficient communication
scientific innovation
continuous training
certain tumors
Extensive training
general challenge
general public
recent clinical evidence
pre-clinical assays
wider array of tumors
innovation-driven society
molecular mechanism of action
identification
products
expertise
current challenges
process of transformation
scientists
reactivity
capacity
facilitators
structure
ability
function
economic value
target toxicity
synergic feedback
objectives
innovative results
complementary approaches
efficiency
Secondments
conventional treatment